Tanja Gatard-Scheikl

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background There are many critical steps for the clinical efficacy of antigen-specific T cell-based immunotherapies among which traffic to and access to tumor beds of effector T cells, are the most(More)
  • 1